SCHEMBL890749

SCHEMBL890749

SCOc1cc(OCS)cc(OCS)c1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891062 0.82 TP53 (0.45) ALDH1A1
SCHEMBL890923 0.79 NQO1 (0.47)
SCHEMBL890886 0.78
SCHEMBL891206 0.73 HDAC3 (0.41) ALDH1A1MAPT
SCHEMBL890561 0.71 INPPL1 (0.33)
SCHEMBL4710446 0.71
SCHEMBL17029442 0.71 HDAC3 (0.50) ALDH1A1MAPT
SCHEMBL16682445 0.68 CCR1 (0.56)
SCHEMBL3943214 0.67 IDO1 (0.58) ALDH1A1MAPT
SCHEMBL6570979 0.67 APP (0.47) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION KUREHA CORPORATION (JP) 2026-03-05 US disclosed
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT KUREHA CORPORATION (JP) 2026-03-05 US disclosed
EP-4679147-A1 MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS TOKUYAMA CORPORATION (JP) 2026-01-14 EP disclosed
US-20250355282-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-11-20 US disclosed
US-20250257162-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-08-14 US disclosed
EP-4582459-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4582463-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4560367-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-05-28 EP disclosed
CN-119768447-A Curable composition, cured product, and method for producing cured product 株式会社吴羽 2025-04-04 CN disclosed
CN-119768439-A Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition 株式会社吴羽 2025-04-04 CN disclosed
US-20100328767-A1 Polarizing Plastic Optical Device and Process for Producing the Same SUNLUX CO., LTD (JP) 2010-12-30 US disclosed
US-7811481-B2 polymerizing a polymerization raw material in contact with polarizing film; raw material composition contains as one main component an isocyanated or isothiocyanated compound which reacts with the hydroxyl of polyvinyl alcohol resin of polarizing film to form a urethane bond or thiourethane bond SUNLUX CO., LTD. (JP) 2010-10-12 US disclosed
US-7741376-B2 Process for preparing dispersed ingredient having metal-oxygen bonds NIPPON SODA CO., LTD. (JP) 2010-06-22 US disclosed
US-20090143498-A1 PROCESS FOR PREPARING DISPERSED INGEDIENT HAVING METAL-OXYGEN BONDS NIPPON SODA CO., LTD (JP) 2009-06-04 US disclosed
US-20070241313-A1 polymerizing a polymerization raw material in contact with polarizing film; raw material composition contains as one main component an isocyanated or isothiocyanated compound which reacts with the hydroxyl of polyvinyl alcohol resin of polarizing film to form a urethane bond or thiourethane bond SUNLUX CO., LTD. (JP) 2007-10-18 US disclosed
EP-1739462-A1 POLARIZING PLASTIC OPTICAL DEVICE AND PROCESS FOR PRODUCING THE SAME Sunlux Co., Ltd. (JP) 2007-01-03 EP disclosed
US-20060239902-A1 Dispersoid having metal-oxygen bonds, metal oxide film, and monomolecular film NIPPON SODA CO., LTD. (JP) 2006-10-26 US disclosed
EP-1580164-A1 DISPERSOID HAVING METAL-OXYGEN BOND, METAL OXIDE FILM, AND MONOMOLECULAR FILM NIPPON SODA CO., LTD. (JP) 2005-09-28 EP disclosed
US-20040197254-A1 Dispersed ingredient having metal-oxygen NIPPON SODA CO., LTD. (JP) 2004-10-07 US disclosed
EP-1422197-A1 DISPERSED INGREDIENT HAVING METAL−OXYGEN NIPPON SODA CO., LTD. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION CROCC, WASF2, DCXR ALDH1A1 1879/4885MAPT 778/4885
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT EHMT1, EHMT2, ASH2L ALDH1A1 265/4885MAPT 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.